steadi
state
alveolar
macrophag
longliv
lungresid
macrophag
sentinel
function
evid
suggest
precursor
origin
embryogenesi
popul
lung
without
replenish
circul
leukocyt
howev
presenc
persist
unclear
follow
human
lung
transplant
ltx
goal
examin
donor
longev
evalu
whether
recipi
origin
seed
transplant
lung
origin
access
use
donorrecipi
hla
mismatch
demonstr
present
bronchoalveolar
lavag
bal
donor
deriv
importantli
recipi
origin
detect
analysi
bal
cell
yr
postltx
reveal
major
donor
deriv
elicit
de
novo
donor
specif
antibodi
dsa
major
postltx
complic
risk
factor
develop
chronic
reject
donor
respond
antihla
framework
ab
secret
inflammatori
cytokin
experiment
murin
model
demonstr
adopt
transfer
allogen
stimul
humor
cellular
immun
respons
alloantigen
lungassoci
selfantigen
led
bronchiolar
obstruct
therefor
donor
deriv
play
essenti
role
dsa
induc
inflammatori
cascad
lead
oblit
airway
diseas
transplant
lung
tissu
resid
macrophag
trm
repres
distinct
cell
popul
term
phenotyp
function
despit
heterogen
trm
adapt
tissu
resid
particip
variou
tissu
specif
immunolog
physiolog
function
requir
lung
microenviron
uniqu
ga
exchang
respiratori
surfac
protect
potenti
airborn
infecti
pollut
agent
alveolar
macrophag
interstiti
macrophag
im
two
recogn
lung
trm
respect
constitut
lung
resid
macrophag
pool
vast
major
occur
lumen
alveoli
bronchiol
compris
leukocyt
present
mous
bronchoalveolar
lavag
bal
steadi
state
matur
mous
lung
contain
human
contain
profession
phagocyt
implic
homeostat
mainten
respiratori
surfac
airway
immun
inflamm
furthermor
stationari
cell
found
attach
alveolar
epithelium
steadi
state
well
inflammatori
challeng
select
loss
result
lung
failur
fatal
hypoxia
sever
morbid
mortal
due
viral
infect
function
impair
link
pulmonari
alveolar
proteinosi
role
gaseou
exchang
immun
surveil
respiratori
interfac
recogn
cellular
origin
persist
andor
turnov
rate
particularli
follow
lung
transplant
ltx
remain
undefin
earlier
consid
compon
lung
mononuclear
phagocyt
system
circul
monocyt
central
precursor
differenti
replenish
number
recent
studi
examin
progenitor
phenotyp
matur
trm
review
oppos
earlier
held
view
trm
includ
kupffer
cell
microglia
langerhan
cell
cardiac
macrophag
osteoclast
prenat
origin
yolksac
erythromyeloid
progenitor
emp
studi
demonstr
neglig
contribut
bone
marrow
bm
deriv
monocyt
recruit
susten
develop
differenti
emp
requir
cellintrins
cellextrins
signal
granulocyt
macrophag
colonystimul
factor
gmcsf
peroxisom
proliferatoractiv
receptor
gamma
depend
longliv
trm
local
maintain
independ
replenish
bm
cell
background
evalu
persist
follow
human
ltx
though
ltx
remain
viabl
treatment
option
variou
endstag
lung
diseas
lung
allograft
undergo
chronic
reject
first
five
year
posttransplant
clinic
diagnos
bronchiol
obliteran
syndrom
bo
develop
immun
respons
mismatch
donor
hla
immun
respons
direct
lungassoci
selfantigen
signific
risk
factor
develop
bo
studi
demonstr
deplet
donor
specif
antibodi
dsa
well
ab
lungassoci
selfantigen
lower
hazard
ratio
develop
bo
view
poor
longterm
success
follow
human
ltx
postul
postltx
persist
donor
influenc
immunolog
respons
direct
donor
antigen
human
ltx
recipi
ltxr
underw
bilater
ltx
barn
jewish
hospit
washington
univers
school
medicin
enrol
studi
ltxr
gave
inform
consent
washington
univers
institut
review
board
approv
studi
recipi
donor
hla
phenotyp
dsa
statu
obtain
histocompat
laboratori
cell
isol
centrifug
bal
fluid
identifi
flow
cytometri
isol
stain
live
cell
sort
bd
fac
aria
ii
cell
sorter
cultur
rpmi
supplement
fb
cultur
supernat
isol
stimul
either
tolllik
receptor
tlr
ligand
human
tlr
agonist
invivogen
phorbol
pma
ionomycin
mab
frameworkhla
isotyp
control
c
cultur
supernat
analyz
human
cytokinechemokin
luminex
panel
thermofish
scientif
endocytosi
access
incub
ph
sensit
phrodor
dextran
bead
analyz
evo
fl
cell
imag
system
thermofish
scientif
wildtyp
b
balbc
mice
wk
male
purchas
charl
river
laboratori
mice
express
transgen
macrophag
tg
describ
earlier
anim
maintain
washington
univers
school
medicin
accord
institut
guidelin
approv
protocol
mice
anesthet
ketaminexylazin
lung
perfus
ml
phosphatebuff
salin
pb
via
right
ventricl
bal
collect
via
cathet
instal
trachea
follow
ml
wash
icechil
pb
supplement
ethylenediamin
tetraacet
acid
bal
cell
pellet
centrifug
min
reconstitut
studi
siglecf
bal
cell
flow
sort
administ
intrabronchi
sinc
averag
yield
wk
male
transfer
ammous
harvest
ratio
lung
tissu
fix
neutral
buffer
formalin
paraffin
embed
section
patholog
evalu
h
e
trichrom
stain
elicit
specif
ab
bal
serum
follow
reconstitut
evalu
stain
mous
cell
cell
isol
kit
stemcel
technolog
bd
facscanto
ii
cell
analyz
enumer
b
reactiv
cell
conduct
stimul
splenocyt
recipi
mice
wk
post
amtransf
irradi
cell
balbc
respect
elispot
assay
bd
bioscienc
detect
mous
de
novo
ab
lungassoci
ag
collagen
v
col
v
conduct
elisa
assay
detail
previou
public
briefli
well
coat
recombin
col
v
protein
quantit
specif
ab
serum
done
probe
hrp
conjug
goat
antimous
ig
jackson
immunoresearch
laboratori
analysi
donor
specif
hla
ab
col
v
autoab
ltx
patient
sera
earlier
describ
enumer
lung
infiltr
col
v
specif
cell
conduct
quantifi
cytokin
secret
cell
elispot
assay
follow
optim
protocol
human
ltxr
receiv
firsttim
bilater
lung
transplant
hla
mismatch
lung
donor
ltxr
encompass
least
one
allel
cohort
donor
recipi
mismatch
hlaa
locu
correl
develop
de
novo
dsa
tabl
subject
underw
ab
direct
immunosuppress
regimen
follow
dsa
resolv
ltxr
addit
col
v
specif
ab
detect
vari
level
clinic
histori
includ
least
one
episod
acut
reject
ltxr
develop
bo
recent
lack
definit
identif
character
major
impedi
fulli
understand
role
fibrosi
immun
inflamm
lung
studi
misharin
et
al
yu
et
al
figur
analysi
elimin
lymphocyt
monocyt
neutrophil
granulocyt
occur
clinic
bal
sampl
furthermor
allow
us
distinguish
donor
recipi
origin
differenti
hla
stain
ltxr
graft
donor
rel
composit
bal
cell
present
tabl
base
morphometr
phenotyp
characterist
constitut
total
bal
cell
isol
human
ltxr
tabl
puriti
figur
ltxr
cohort
donor
recipi
hla
mismatch
either
tabl
analyz
bal
sampl
encompass
three
possibl
combin
ie
x
allel
analyz
bal
sampl
rang
day
postltx
vast
major
identifi
bal
cell
group
posit
donorhla
figur
significantli
carri
uniqu
recipi
hlaa
detect
group
total
popul
posit
donor
hla
likewis
detect
group
express
recipi
hla
sinc
probe
encompass
marker
donor
recipi
hla
feasibl
assess
donor
vs
recipi
contribut
pool
significantli
major
group
donor
deriv
detect
contribut
recipi
two
group
allow
us
estim
respect
persist
donor
replac
cell
recipi
origin
sinc
mhc
class
ubiquit
express
nucleat
cell
clone
clone
known
crossreact
chose
focu
two
hlaa
locu
mismatch
collect
experiment
set
signific
proport
detect
donor
deriv
indic
longterm
persist
without
replac
recipi
cell
year
postltx
figur
next
determin
postltx
respons
variou
inflammatori
stimuli
tlr
ligand
donor
specif
hla
ab
use
highli
purifi
isol
via
flow
sort
determin
respons
panel
human
tlr
agonist
mitogen
pma
ionomycin
ab
antihla
isotyp
control
cytokin
product
express
fold
increas
stimul
cell
unstimul
cell
overal
respond
stimuli
albeit
differenti
rang
magnitud
figur
stimuli
mimick
infect
viru
gram
posit
neg
bacteria
induc
statu
intracellular
infect
upregul
inflammatori
cytokin
includ
promin
addit
chemokin
includ
macrophag
inflammatori
protein
rant
mig
involv
chemotaxi
cell
inflammatori
cell
also
elicit
cytokin
chemokin
signatur
part
broader
immun
respons
cell
includ
limit
macrophag
indic
preserv
respons
variou
infecti
inflammatori
stimuli
postltx
period
furthermor
tlr
stimuli
induc
macrophag
produc
chemokin
import
neutrophil
recruit
degranul
fold
tabl
contrast
expect
cytokin
signatur
lack
cell
specif
cytokin
indic
absenc
contamin
cell
purif
protocol
strike
find
respons
antihla
induc
uniqu
signatur
stimul
fold
fold
fold
rant
fold
fold
fold
fold
fold
mig
fold
isotyp
control
figur
importantli
also
induc
fold
compar
isotyp
treatment
tabl
taken
togeth
data
demonstr
donor
purifi
bal
follow
ltx
abl
respond
infect
also
react
mhc
ligat
ab
result
secret
inflammatori
cytokin
assess
endocytosi
ph
sensit
dextran
bead
bead
follow
intern
acid
endosom
lysosom
compart
fluoresc
allow
detect
follow
puls
figur
demonstr
bead
uptak
indic
preserv
particl
endocytosi
postltx
murin
bal
cell
identifi
siglecf
figur
util
novel
tg
mous
express
full
length
transgen
macrophag
evalu
reconstitut
nearli
tg
express
b
figur
uniqu
express
surfac
transgen
tg
enabl
us
examin
effect
restrict
donor
specif
mhc
mismatch
elicit
donor
specif
alloimmun
evalu
whether
transfer
tg
tg
recipi
induc
specif
immun
respons
parallel
also
carri
allogen
transfer
tg
recipi
syngen
transfer
tg
tg
recipi
transfer
recipi
develop
alloantigen
reactiv
lungresid
cell
figur
alloab
bal
fluid
serum
figur
analyz
adopt
transfer
tg
stimul
alloantigen
specif
cell
respons
elicit
detect
ab
bal
fluid
well
serum
sinc
donor
express
transgen
recogn
foreign
antigen
import
note
donor
tg
recipi
ident
mhc
class
ii
ia
b
therefor
donor
capabl
prime
ia
b
restrict
reactiv
cell
engraft
express
equival
level
surfac
mhc
ii
present
nativ
indic
optim
antigen
present
abil
figur
taken
togeth
demonstr
specif
ab
cell
respons
suggest
mismatch
mhc
antigen
suffici
elicit
donor
specif
immun
respons
earlier
develop
murin
oblit
airway
diseas
model
administr
exogen
mhc
ab
nativ
lung
induc
bronchiol
clinic
correl
human
bo
present
studi
transfer
model
evalu
patholog
effect
de
novo
dsa
small
airway
obstruct
fibrosi
increas
peribronchiolar
leukocyt
cluster
greater
epitheli
hypertrophi
hyperplasia
evid
compar
group
figur
addit
higher
deposit
collagen
extracellular
matrix
protein
higher
occurr
small
airway
obstruct
mice
indic
respiratori
impair
histopatholog
assess
transfer
group
present
figur
allogen
transfer
stimul
dsa
result
signific
loss
bronchiolar
architectur
concomit
increas
small
airway
inflamm
obstruct
view
elicit
de
novo
dsa
figur
bronchiolar
obstruct
figur
examin
stimul
lungassoci
selfantigen
col
v
specif
autoimmun
follow
transfer
mean
serum
titer
anticol
v
transfer
mice
respect
significantli
higher
transfer
group
measur
figur
furthermor
stimul
significantli
greater
col
v
reactiv
secret
cell
figur
mean
specif
secret
cell
cell
respect
col
v
reactiv
cell
cell
respect
selfantigen
reactiv
cell
transfer
group
remain
cell
taken
togeth
stimul
cell
develop
ab
direct
lungassoci
antigen
indic
mhc
mismatch
suffici
induc
humor
cellular
immun
respons
lungassoci
selfantigen
despit
improv
surgic
techniqu
postop
care
incid
bo
continu
primari
obstacl
longterm
success
ltx
develop
de
novo
dsa
mismatch
donor
hla
ab
lungassoci
selfantigen
consid
major
risk
factor
bo
develop
role
dsa
induc
lung
inflamm
bo
larg
unknown
partli
due
lack
uniform
experiment
approach
definit
character
termin
differenti
trm
express
distinct
surfac
marker
compar
tissu
resid
circulatori
macrophag
recent
describ
flow
cytometr
analys
allow
unambigu
identif
human
mous
enabl
distinguish
passeng
leukocyt
gener
believ
recipi
stem
cell
seed
transplant
organ
endotheli
cell
macrophag
repopul
graft
potenti
minim
host
immun
detect
howev
dichotomi
immunolog
complic
poor
prognosi
associ
ltx
intrigu
us
investig
postltx
persist
donor
contribut
chronic
reject
major
lung
trm
constitut
profession
phagocyt
bloodair
interfac
first
time
demonstr
donor
persist
follow
ltx
long
period
yr
respond
hla
specif
ab
result
secret
proinflammatori
cytokin
find
twofold
implic
first
longterm
surviv
donor
bear
donorhla
transplant
lung
may
serv
repositori
mismatch
hla
antigen
second
find
demonstr
proinflammatori
respons
mhc
ligat
indic
put
role
mediat
dsa
induc
pathogenesi
find
longterm
susten
follow
human
ltx
inabl
detect
recipi
deriv
cellular
chimer
compart
contrast
earlier
publish
studi
disagr
due
differ
experiment
method
target
cell
studi
exampl
report
et
al
use
dna
microsatellit
describ
rapid
turnov
donor
bal
cell
lineag
analysi
human
lack
express
monocyt
studi
judson
et
al
analyz
pleural
cell
chimer
primarili
unilater
ltx
patient
cellular
composit
pleural
lavag
fluid
includ
lymphoid
myeloid
cell
lack
nakata
et
al
kennedi
et
al
studi
reconstitut
prolifer
bal
cell
follow
bm
transplant
bmt
report
appear
bm
deriv
bal
around
day
postbmt
author
base
conclus
lymphocytedeplet
monocyt
macrophag
purifi
follow
irradi
bmt
therefor
due
lack
consist
analysi
difficult
interpret
result
recipi
reconstitut
approach
identifi
base
surfac
marker
enabl
us
distinguish
im
monocyt
neutrophil
lymphocyt
granulocyt
addit
use
hla
allel
abl
identifi
either
donor
recipi
origin
recent
consist
misidentifi
misrepres
regard
phenotyp
lineag
specif
recent
studi
conclud
yolksac
deriv
fetal
monocyt
circul
hematopoiet
stem
cell
hsc
deriv
monocyt
precursor
develop
genet
reconstitut
parabiosi
experi
also
confirm
circul
monocyt
minim
contribut
homeostat
pool
constitut
induc
fate
map
embryon
cell
indic
yolksac
emp
accumul
fetal
liver
give
rise
hsc
driven
hematopoiesi
minim
replac
compart
moreov
transplant
fetal
liver
cell
follow
deplet
clodron
liposom
lethal
irradi
result
effici
reconstitut
cell
im
hand
blood
monocyt
deriv
demonstr
high
turnov
rate
impact
ischemia
reperfus
injuri
iri
associ
ltx
current
unknown
rat
ltx
model
viabl
isol
bal
cell
follow
transplant
suggest
minim
effect
iri
surviv
though
specif
test
influenc
iri
studi
result
suggest
human
endur
iri
stress
persist
year
postltx
experiment
model
longterm
replac
steadi
state
hsc
cell
neglig
slow
partial
turnov
report
bmt
follow
myeloabl
irradi
infect
influenza
viru
high
dose
endotoxin
challeng
due
old
age
deplet
homeostat
pool
remain
unclear
though
phenotyp
transcript
differ
yolksac
deriv
nativ
neodifferenti
bm
hematopoiesi
cohort
ltxr
receiv
irradi
treatment
remain
free
document
viral
infect
followup
period
exist
neg
pressur
donor
surviv
unlik
donor
respond
tlr
agonist
mhc
ligat
respons
tlr
stimuli
indic
function
preserv
first
line
innat
defens
respiratori
interfac
demonstr
inflammatori
respons
donor
follow
mhc
ligat
agreement
report
domin
role
donor
endotheli
cell
antihla
induc
inflamm
addit
conclus
demonstr
donor
ex
vivo
assay
stimul
inflammatori
cytokin
respons
antihla
extracorpor
remov
dsa
shown
reduc
inflammatori
cytokin
increas
antiinflammatori
cytokin
signific
clinic
implic
may
contribut
dsa
induc
pathogenesi
fibrot
inflammatori
lung
diseas
investig
whether
reconstitut
viabl
adopt
transfer
allogen
singl
mhc
mismatch
intrabronchi
administr
tg
result
persist
stabl
reconstitut
rate
figur
donor
local
alveoli
detect
even
four
month
posttransf
suggest
viabl
engraft
sinc
tg
carri
surfac
alloantigen
evalu
whether
led
alloimmun
evalu
elicit
local
well
system
alloab
follow
transfer
stimul
ab
cell
respons
alloantigen
figur
c
lungassoci
selfantigen
figur
b
concomit
bronchiolar
obstruct
fibrosi
figur
serv
antigen
present
cell
natur
infect
vaccin
earlier
studi
report
persist
donor
induct
alloab
bal
serum
cell
follow
allogen
transfer
genet
mismatch
donor
recipi
studi
major
encompass
mhc
ii
nonmhc
loci
contrast
transfer
experi
perform
studi
includ
one
defin
allel
mismatch
help
us
determin
immunogen
mhc
mismatch
limit
studi
narrow
probe
rang
permit
analysi
human
bal
cell
organ
donor
recipi
genet
mismatch
includ
least
exclud
number
potenti
bal
sampl
result
small
sampl
size
nevertheless
find
donor
deriv
engraft
lung
first
demonstr
longterm
persist
nativ
follow
human
ltx
studi
evalu
causal
andor
consequ
donor
develop
bo
possibl
addit
cellular
molecular
process
particip
develop
dsa
bronchiolar
obstruct
lead
bo
howev
abil
induc
dsa
stimul
mhc
ab
demonstr
import
role
dsa
induc
immunopathogenesi
lead
chronic
lung
allograft
reject
refer
web
version
pubm
central
supplementari
materi
work
support
grant
nih
bjc
foundat
tm
grant
nih
mt
fz
support
state
scholarship
fund
china
scholarship
council
imiquimod
type
b
pma
inonomycin
use
ngml
ngml
respect
hla
specif
mab
isotyp
control
c
use
studi
effect
mhc
crosslink
flow
sort
seed
plate
cellswel
releas
cytokin
hr
stimul
measur
cultur
supernat
luminex
panel
mean
fluoresc
intens
mfi
individu
analyt
express
fold
increas
stimul
cell
compar
unstimul
cell
data
select
analyt
repres
cultur
present
comput
valu
pgml
analyt
given
tabl
b
particl
endocytosi
access
incub
ph
sensit
phrodor
dextran
mw
bead
min
cell
stain
nucblu
live
readi
probe
visual
nucleu
analyz
evo
fl
cell
imag
system
repres
merg
imag
bright
field
red
blue
fluoresc
given
scale
bar
histopatholog
assess
lung
follow
adopt
transfer
paraffin
embed
tissu
section
analyz
leukocyt
infiltr
h
e
fibrosi
masson
trichrom
b
slide
score
accord
averag
score
five
field
present
three
mice
per
group
analyz
multipl
ttest
appli
statist
signific
determin
use
holmsidak
method
p
valu
indic
scale
bar
allogen
reconstitut
induc
lungassoci
antigen
specif
autoimmun
elicit
serum
ab
col
v
wk
post
transfer
measur
elisa
b
accumul
col
v
specif
cell
evalu
elispot
assay
bd
bioscienc
singl
cell
suspens
prepar
lung
digest
liberas
tl
roch
life
scienc
dnasei
sigmaaldrich
min
lung
leukocyt
isol
singl
cell
suspens
ficollpaqu
sigmaaldrich
gradient
centrifug
one
million
lung
leukocyt
ad
per
well
supplement
splenocyt
irradi
gy
antigen
present
cell
cell
stimul
col
v
protein
cytokin
produc
spot
enumer
individu
serum
nayak
et
al
page
tabl
summari
hlaa
mismatch
lung
allograft
donor
recipi
clinic
featur
follow
human
lung
transplant
